Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 22, Issue 8, 2000, Pages 609-613

  Ogura, H ^a   Kosasa, T ^a   Kuriya, Y ^a   Yamanishi, Y ^a  

^a NONE   (Japan)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Cholinest erase inhibitor; Donepezil hydrochloride; Ipidacrine; Physostigmine; Rivastigmine; Tacrine; TAK 147

Indexed keywords

ACETYLCHOLINESTERASE; AMIRIDINE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE; DONEPEZIL; PHYSOSTIGMINE; RIVASTIGMINE; TACRINE; ZANEPEZIL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; MALE; NONHUMAN; RAT;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMINOQUINOLINES; ANIMALS; BENZAZEPINES; BRAIN; BUTYRYLCHOLINESTERASE; CARBAMATES; CHOLINESTERASE INHIBITORS; INDANS; INHIBITORY CONCENTRATION 50; MALE; PHENYLCARBAMATES; PHYSOSTIGMINE; PIPERIDINES; RATS; TACRINE; TIME FACTORS;

EID: 0034467344     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2000.22.8.701373     Document Type: Article

References (33)

1. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies
2. Selective loss of central cholinergic neurons in Alzheimer's disease
3. Neurotransmitter enzyme abnormalities in senile dementia: Choline acetyltransferase and glutamic acid decarboxylase in necropsy brain tissue
4. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
5. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
6. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds
7. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats
8. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicenter, randomized, double-blind, placebo-controlled trial
9. Donepezil improves cognitive and global function in Alzheimer's disease: A 15-week double-blind, placebo-controlled study
10. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
11. Donepezil
12. Cholinesterase inhibitors for Alzheimer's disease therapy: From tacrine to future applications
13. Side effects of long acting cholinesterase inhibitor
14. Analysis of plasma physostigmine concentrations by liquid chromatography
15. Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors
16. Clinical development of exelone (ENA-713): The Adena programme
17. Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8- yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models
18. Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8- yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats
19. Effect of 9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta-(b)-quinoline monohydrate hydrochloride (NIK-247) on cholinergic enzyme activity in rats
20. Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia
21. Mode of action of anticholinesterases
22. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine: Comparison with physostigmine
23. A new and rapid colorimetric determination of acetylcholinesterase activity
24. Huperzine A, a novel promising acetylcholinesterase inhibitor
25. A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066
26. Brain selective inhibition of acetylcholinesterase: A novel approach to therapy for Alzheimer's disease
27. 5,7-dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1, 2-benzisoxazol-6-one: A potent and centrally-selective inhibitor of acetylcholinesterase with an improved margin of safety
28. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos
29. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats
30. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats
31. Physostigmine, tacrine and metrifonate: The effect of multiple doses on acetylcholine metabolism in rat brain
32. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo
33. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex